For help on how to get the results you want, see our search tips.
22 results
Medicine
Referrals Remove Referrals filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Referral type
Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter
Article 20 procedures Remove Article 20 procedures filter
Referral safety status
Yes Remove Yes filter
Categories
Human Remove Human filter
-
List item
Referral: Janus kinase inhibitors (JAKi)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/01/2023, EC decision date: 10/03/2023, Last updated: 22/05/2023 -
List item
Referral: Rubraca
rucaparib, associated names: Rubraca, Article 20 procedures
Status: European Commission final decision, opinion/position date: 21/07/2022, EC decision date: 21/09/2022, Last updated: 17/10/2022 -
List item
Referral: Picato
ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020 -
List item
Referral: Yondelis
trabectedin, associated names: Yondelis, Article 20 procedures
Status: European Commission final decision, opinion/position date: 24/07/2020, EC decision date: 24/09/2020, Last updated: 09/10/2020 -
List item
Referral: Xeljanz
tofacitinib, associated names: Xeljanz, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 31/01/2020, Last updated: 06/03/2020 -
List item
Referral: Lemtrada
alemtuzumab, associated names: Lemtrada, Article 20 procedures
Status: European Commission final decision, opinion/position date: 14/11/2019, EC decision date: 16/01/2020, Last updated: 04/02/2020 -
List item
Referral: Lartruvo
olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019 -
List item
Referral: Octagam
human normal immunoglobulin, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 04/10/2010, Last updated: 18/11/2013 -
List item
Referral: Buflomedil
buflomedil, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 13/02/2012, Last updated: 13/06/2012 -
List item
Referral: Meprobamate
meprobamate, associated names: Equanil and other trade names, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 19/01/2012, EC decision date: 30/03/2012, Last updated: 08/06/2012 -
List item
Referral: Somatropin
somatropin, associated names: Genotropin, Humatrope, Maxomat, Norditropin, Saizen, Zomacton, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 27/02/2012, Last updated: 23/04/2012 -
List item
Referral: Bufexamac
bufexamac, associated names: Parfenac, Bufal, Calmaderm, Fansamac, Mastu S, Parfenoide, Proctosan, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 10/11/2011 -
List item
Referral: Ketoprofen topical
ketoprofen, associated names: Fastum, Ketum, Orudis, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 29/11/2010, Last updated: 28/10/2011 -
List item
Referral: Benfluorex
benfluorex, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 14/06/2010, Last updated: 27/07/2011 -
List item
Referral: Iodocasein- and thiamine-containing medicinal products
iodocasein, thiamine nitrate, associated names: Antiadiposo, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 10/10/2009, Last updated: 27/05/2011 -
List item
Referral: Sibutramine
sibutramine, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 21/01/2010, EC decision date: 06/08/2010, Last updated: 09/03/2011 -
List item
Referral: Moxifloxacin
moxifloxacin, associated names: Avalox, Avelox, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 24/10/2008, Last updated: 24/07/2008 -
List item
Referral: Lumiracoxib
lumiracoxib, associated names: Prexige, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 13/12/2007, Last updated: 14/12/2007 -
List item
Referral: Aprotinin
aprotinin, associated names: Trasylol, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/11/2007, EC decision date: 15/02/2008, Last updated: 22/11/2007 -
List item
Referral: Carisoprodol
carisoprodol, associated names: Somadril, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/11/2007, EC decision date: 05/02/2008, Last updated: 16/11/2007 -
List item
Referral: Clobutinol
clobutinol, associated names: Silomat, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 18/10/2007, EC decision date: 30/11/2007, Last updated: 19/10/2007 -
List item
Referral: Nimesulide
nimesulide, associated names: Aulin, Nimed, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 16/10/2009, Last updated: 21/09/2007